Altamira Therapeutics Ltd.: xbrl:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset

Value{"unit": "CHF", "value": 360541}
Period2019-01-01 – 2019-12-31
Statuscurrent
EntityAltamira Therapeutics Ltd.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001213900-20-009292
Retrieved: 2026-08-19T16:24:22.861909+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Cite as: FACTANKER, https://factanker.com/fact/87367875-55d7-45b7-bb87-1d2ae74dcf22

History